Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, (1), CD000069

Danazol for Unexplained Subfertility

Affiliations
Review

Danazol for Unexplained Subfertility

E Hughes et al. Cochrane Database Syst Rev.

Abstract

Background: The synthetic androgen Danazol, was developed in the 1970's as a treatment for endometriosis. Its use was soon advocated in women with unexplained subfertility. Two randomised trials were subsequently conducted to assess the effectiveness of danazol in this population.

Objectives: The objective of this review was to assess the effect of danazol on live birth rate in women with unexplained subfertility.

Search strategy: We searched the Cochrane Menstrual Disorders and Sub-fertility Group's specialised register of trials (searched November , 2006) the Cochrane Register of Controlled Trials (The Cochrane Library, Issue 4, 2006), MEDLINE (1966-November 2006), EMBASE (1980 - November 2006) and reference lists of articles.

Selection criteria: Randomised trials of danazol compared with placebo or no treatment in women with unexplained subfertility.

Data collection and analysis: Data were extracted by two reviewers EH and GT.

Main results: Two trials involving seventy-one women were included. There was no statistically significant difference in the live birth/ ongoing pregnancy rate between danazol and placebo at the end of treatment (OR 1.16, 95% CI 0.0 to 8.29; P=0.36) or at the end of follow-up (OR 2.41; 95% CI 0.59, 9.82; P=0.22). There was no significant difference in clinical pregnancies following treatment (OR 0.14, 95% CI 0.01, 2.26; P=0.17), however there were significantly more clinical pregnancies during the follow-up period in the danazol group compared with the placebo group (OR 3.15, 95%CI 0.98, 10.10; P<0.05). Multiple side effects were reported.

Authors' conclusions: Available data demonstrate no evidence of the benefit of danazol for unexplained subfertility. Although there is insufficient evidence to be certain of this, the need for contraception during treatment and the adverse effects and costs of danazol, make its use for this problem unwarranted. The increased pregnancy rate in the long term follow-up data may be attributable to additional therapies and did not influence the live birth/ongoing pregnancy data.

Update of

  • Danazol for Unexplained Infertilty
    E Hughes et al. Cochrane Database Syst Rev (2), CD000069. PMID 10796484. - Review
    There is not enough evidence to evaluate the effect of danazol on pregnancy rates in women with unexplained subfertility. The need to use contraception during danazol tre …

Similar articles

  • Danazol for Unexplained Infertilty
    E Hughes et al. Cochrane Database Syst Rev (2), CD000069. PMID 10796484. - Review
    There is not enough evidence to evaluate the effect of danazol on pregnancy rates in women with unexplained subfertility. The need to use contraception during danazol tre …
  • Ovulation Suppression for Endometriosis
    E Hughes et al. Cochrane Database Syst Rev (3), CD000155. PMID 17636607. - Review
    There is no evidence of benefit in the use of ovulation suppression in subfertile women with endometriosis who wish to conceive.
  • Antioxidants for Female Subfertility
    MG Showell et al. Cochrane Database Syst Rev (8), CD007807. PMID 23913583. - Review
    The quality of the evidence in the 'antioxidant versus placebo/no treatment' and in the 'antioxidant versus antioxidant' comparisons was assessed to be 'very low'. Antiox …
  • Ovulation Suppression for Endometriosis
    E Hughes et al. Cochrane Database Syst Rev (3), CD000155. PMID 12917884. - Review
    These results rule out a benefit of more than a 15% increase in odds, and do not justify the risk of side effects when used as therapy for endometriosis-associated subfer …
  • Danazol for Heavy Menstrual Bleeding
    H Beaumont et al. Cochrane Database Syst Rev (3), CD001017. PMID 17636649. - Review
    Danazol appears to be an effective treatment for heavy menstrual bleeding compared to other medical treatments. The use of Danazol may be limited by its side effect profi …
See all similar articles

Cited by 1 PubMed Central articles

LinkOut - more resources

Feedback